A panel of Canadian health experts on Tuesday said AstraZeneca's COVID-19 vaccine could be used in people aged 65 years and older after initially recommending against the idea.
The National Advisory Committee on Immunization said it was basing its new guidelines on three recent real-world studies that examined the effectiveness of the vaccine. (https://bit.ly/3thLc1Q) The committee had said on March 1 that AstraZeneca doses should only be given to those aged from 18 to 64 because clinical trials had featured very few people 65 or older.
"There is now real-world evidence from the United Kingdom (which) who has been administering